familymednews.com
VH-studio/Shutterstock By Preston Smith/Sept. 7, 2021 12:34 pm EDT Thinking outside of the box is the only proper way to live life, right? Well, that’s at least what we at The List think, and it can work wonders when considering home renovations. More specifically, it’s paramount that you get creative in the kitchen and your pantry — and not just in […]
Continue reading »
(HealthDay)—Among women giving birth, the rates of hepatitis C virus (HCV) infection increased more than 400 percent from 2000 to 2015, with rates much higher among those with opioid use disorder, according to research published in the Oct. 4 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Jean Y. Ko, Ph.D., from the […]
Continue reading »
(HealthDay)—Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through 6 and compensated cirrhosis, the U.S. Food and Drug Administration announced last week. Mavyret is the first eight-week treatment approved for any treatment-naive HCV patients, regardless of cirrhosis status or […]
Continue reading »
(HealthDay)—Taking the hepatitis C drugs Mavyret, Zepatier or Vosevi can trigger rare cases of severe liver problems or liver failure in patients who already have moderate-to-severe liver impairment, the U.S. Food and Drug Administration warned Wednesday. The agency has identified 63 cases of worsening liver function, some resulting in liver failure or death, among patients taking the drugs. While the […]
Continue reading »
A large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer. Researchers at UT Southwestern Medical Center studied the records of patients who had been successfully treated for liver cancer at 31 medical centers in North America, comparing those who were and were not given direct-acting antivirals for […]
Continue reading »
(HealthDay)—A guideline published in the June 4 issue of CMAJ, the journal of the Canadian Medical Association, provides updated evidence-based recommendations for the treatment of patients with chronic hepatitis C virus (HCV) infection. Hemant Shah, M.D., from the University of Toronto, and colleagues conducted a focused literature search to update the evidence base used in the 2015 guideline. The resulting […]
Continue reading »
New research: High burden of hepatitis C among people who inject drugs highlights the urgent need for harm reduction and treatment strategies Globally, more than one in three (39%) people who have injected drugs in the last year are living with hepatitis C infection, according to new research from the National Drug and Alcohol Research Centre and the Kirby Institute […]
Continue reading »
Highly effective drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the U.S. in 2014. But both public and private insurers continue to deny coverage for these costly drugs at high rates nationwide, despite efforts to remove treatment restrictions, according to a new study published in Open Forum Infectious Diseases. The […]
Continue reading »
Due to the opioid epidemic, hepatitis C virus (HCV) is increasingamong pregnant women, resulting in a greater risk of perinatal transmission and HCV infection among children. Despite this increased prevalence, HCV-exposed infants are not adequately screened and many pediatric HCV infections remain undetected, according to a new study from researchers at Magee-Womens Research Institute (MWRI). The results are reported in […]
Continue reading »
If a headline says research shows a diet rich in a food ‘could help fight cancer’ then our advice would be to read on with a critical eye. Vitamin C is a great example of this. In fact, headlines from last year could have you believe that eating oranges might cure cancer. This media interest stemmed from two studies testing […]
Continue reading »